HJB - Your Trusted Biologics CDMO Partner
HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB
Background
A case of standard mAb perfusion process development for phase I. Developed process from top 3 clones to locked process with final clone using proprietary media.
Results
Developed and locked process using our standard platform in 3 months.
Long time steady state perfusion with stable cell growth, metabolism, productivity and product quality. VPR reach 4~5 g/L/day.
